Evaluating the safety and efficacy of thalamic DBS in treating traumatic brain injury

The safety and efficacy of deep brain stimulation.

Pharmalittle: FDA grants full approval to Alzheimer’s drug; Sanders blocks NIH nominee over drug costs

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

July 7, 2023

Opinion | Lessons for Healthcare From the Global IT Outage

Moura is a clinical neurologist and a health informatics expert. The recent global information technology (IT) outage, which spurred thousands of flight cancellations and significant

July 27, 2024

Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more

Rise and shine, everyone, another busy day is on the way. How so? The evidence presented itself early this morning as the official mascots dashed

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.